AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (325.1 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Advances in the treatment of metastatic prostate cancer in China

Baojun Wang1, Zhenhua Liu2, Luyao Yang2, Xu Zhang1 ( )
Department of Urology, Chinese PLA General Hospital, Beijing 100853, China
Value & Implementation, Global Medical & Scientific Affairs, MSD China, Shanghai 200233, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 22 Issue 5,
May 2025
Pages 433-438
DOI: 10.20892/j.issn.2095-3941.2025.0065

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Wang B, Liu Z, Yang L, et al. Advances in the treatment of metastatic prostate cancer in China. Cancer Biology & Medicine, 2025, 22(5): 433-438. https://doi.org/10.20892/j.issn.2095-3941.2025.0065

681

Views

27

Downloads

0

Crossref

0

Web of Science

1

Scopus
Received: 07 March 2025
Accepted: 31 March 2025
Published: 19 May 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License